Correction: Benzoflavone derivatives as potent antihyperuricemic agents
Abstract
Correction for ‘Benzoflavone derivatives as potent antihyperuricemic agents’ by Jatinder V. Singh et al., MedChemCommun, 2019, DOI: 10.1039/c8md00512e.
Maintenance work is planned from 21:00 BST on Tuesday 20th August 2024 to 21:00 BST on Wednesday 21st August 2024, and on Thursday 29th August 2024 from 11:00 to 12:00 BST.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to log in or to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
E-mail:
singh.harbinder40@gmail.com
b TERI-Deakin Nanobiotechnology Centre, The Energy and Resources Institute, TERI Gram, Gual Pahari, Gurugram, Haryana 122001, India
Correction for ‘Benzoflavone derivatives as potent antihyperuricemic agents’ by Jatinder V. Singh et al., MedChemCommun, 2019, DOI: 10.1039/c8md00512e.
J. V. Singh, G. Mal, G. Kaur, M. K. Gupta, A. P. Singh, K. Nepali, H. Singh, S. Sharma and P. M. S. Bedi, Med. Chem. Commun., 2019, 10, 182 DOI: 10.1039/C9MD90002K
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content